Quest for the right Drug
דאלאצין סי כמוסות 150 מ"ג DALACIN C CAPSULES 150 MG (CLINDAMYCIN HYDROCHLORIDE)
תרופה במרשם
תרופה בסל
נרקוטיקה
ציטוטוקסיקה
צורת מתן:
פומי : PER OS
צורת מינון:
קפסולות : CAPSULES
עלון לרופא
מינוניםPosology התוויות
Indications תופעות לוואי
Adverse reactions התוויות נגד
Contraindications אינטראקציות
Interactions מינון יתר
Overdose הריון/הנקה
Pregnancy & Lactation אוכלוסיות מיוחדות
Special populations תכונות פרמקולוגיות
Pharmacological properties מידע רוקחי
Pharmaceutical particulars אזהרת שימוש
Special Warning עלון לרופא
Physicians Leaflet
Posology : מינונים
2. DOSAGE AND ADMINISTRATION Administer Dalacin C Capsules with a full glass of water (approximately 200 to 250 mL) and at least 30 minutes before lying down to reduce the potential for esophageal irritation (See section 6). Dosage in Adults Clindamycin hydrochloride capsules (oral administration): 600-1800 mg/day divided in 2, 3 or 4 equal doses. Dosage in Children (over 1 month of age) Clindamycin hydrochloride capsules (oral administration): To avoid the possibility of esophageal irritation, clindamycin HCl capsules should be taken with a full glass of water and no less than 30 minutes before lying down.Doses of 8-25 mg/kg/day in 3 or 4 equal doses. Dosage in Elderly Pharmacokinetic studies with clindamycin have shown no clinically important differences between young and elderly subjects with normal hepatic function and normal (age-adjusted) renal function after oral or intravenous administration. Therefore, dosage adjustments are not necessary in the elderly with normal hepatic function and normal (age-adjusted) renal function (see Section 4.2 Pharmacokinetic Properties). Dosage in Renal Impairment Clindamycin dosage modification is not necessary in patients with renal insufficiency. Dosage in Hepatic Impairment Clindamycin dosage modification is not necessary in patients with hepatic insufficiency. Dosage in Specific Indications (a) Treatment of Beta-Hemolytic Streptococcal Infections Refer to the dosage recommendations above. Treatment should be continued for at least 10 days. (b) Treatment of Chlamydia trachomatis Cervicitis Clindamycin hydrochloride capsules orally 450-600 mg 4 times daily for 10-14 days . (c) Treatment of Toxoplasmic Encephalitis in Patients with AIDS Clindamycin hydrochloride orally 600-1200 mg every 6 hours for 2 weeks followed by 300-600 mg orally every 6 hours. The usual total duration of therapy is 8 to 10 weeks. The dose of pyrimethamine is 25 to 75 mg orally each day for 8 to 10 weeks. Folinic acid 10 to 20 mg/day should be given with higher doses of pyrimethamine. (d) Treatment of Pneumocystis carinii Pneumonia in Patients with AIDS Clindamycin hydrochloride 300 to 450 mg orally every 6 hours for 21 days, and Primaquine 15 to 30 mg dose orally once daily for 21 days. (e) Treatment of Acute Streptococcal Tonsillitis/Pharyngitis Clindamycin hydrochloride capsules 300 mg orally twice daily for 10 days. (f) Dosage for Additional Therapeutic Activity - Treatment of Malaria: Uncomplicated Malaria/P falciparum Adults: Quinine sulfate: 650 mg orally three times daily for 3 or 7 days plus clindamycin: 20 mg base/kg/day orally divided three times daily for 7 days. Children: Quinine sulfate: 10 mg/kg orally three times daily for 3 or 7 days plus clindamycin: 20 mg base/kg/day orally divided three times daily for 7 days. Severe malaria Adults: Quinidine gluconate: 10 mg/kg loading dose IV over 1-2 hrs, then 0.02 mg/kg/min continuous infusion for at least 24 hours (for alternative dosing regimen please refer to quinidine label). Once parasite density <1% and patient can take oral medication, complete treatment with oral quinine, dose as above, plus clindamycin: 20 mg base/kg/day orally divided three times daily for 7 days. If patient not able to take oral medication, give 10 mg base/kg clindamycin loading dose IV followed by 5 mg base/kg IV every 8 hours. Avoid rapid IV administration. Switch to oral clindamycin (oral dose as above) as soon as patient can take oral medication. Treatment course = 7 days. Children: Quinidine gluconate: Same mg/kg dosing and recommendations as for adults plus clindamycin: 20 mg base/kg/day orally divided three times daily for 7 days. If patient not able to take oral medication, give 10 mg base/kg clindamycin loading dose IV followed by 5 mg base/kg IV every 8 hours. Avoid rapid IV administration. Switch to oral clindamycin (oral dose as above) as soon as patient can take oral medication. Treatment course = 7 days. (g) Prophylaxis of Endocarditis in Patients Sensitive to Penicillin Clindamycin hydrochloride capsules (oral administration). Adults: 600 mg 1 hour before procedure; children: 20 mg/kg 1 hour before procedure.
שימוש לפי פנקס קופ''ח כללית 1994
יירשם ע"י רופא מומחה למחלות זיהומיות או רופא שהורשה ע"י הנהלת המחוז.
תאריך הכללה מקורי בסל
01/01/1995
הגבלות
תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת
מידע נוסף
עלון מידע לצרכן
02.09.13 - עלון לצרכן 10.02.22 - עלון לצרכן אנגלית 10.02.22 - עלון לצרכן עברית 10.02.22 - עלון לצרכן ערבית 06.11.22 - עלון לצרכן אנגלית 06.11.22 - עלון לצרכן עברית 06.11.22 - עלון לצרכן ערבית 12.10.23 - עלון לצרכן עברית 06.01.24 - עלון לצרכן אנגלית 06.01.24 - עלון לצרכן ערבית 16.06.20 - החמרה לעלון 12.09.22 - החמרה לעלון 05.12.23 - החמרה לעלוןלתרופה במאגר משרד הבריאות
דאלאצין סי כמוסות 150 מ"ג